SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127000
Filing Date
2023-04-28
Accepted
2023-04-28 16:16:10
Documents
5
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d459288ddef14a.htm DEF 14A 736495
2 GRAPHIC g459288dsp001.jpg GRAPHIC 160223
3 GRAPHIC g459288dsp002.jpg GRAPHIC 136611
4 GRAPHIC g459288g11a31.jpg GRAPHIC 30696
5 GRAPHIC g459288g56j54.jpg GRAPHIC 36205
  Complete submission text file 0001193125-23-127000.txt   1229549
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38473 | Film No.: 23866449
SIC: 2834 Pharmaceutical Preparations